GlassScriptPhysician profile
Amy J Dichiara
NPI 1336350990
$848.28
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $61.38 · 2021: $254 · 2022: $55.17 · 2023: $20.71 · 2024: $16.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $37.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $37.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $286.27 | 2019-2024 | Linzess, Viberzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $228.18 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $71.46 | 2019-2020 | |
| Janssen Biotech, INC. | $51.87 | 2019-2021 | |
| Pfizer INC. | $43.22 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $42.75 | 2022 | |
| Shire North American Group INC | $29.46 | 2019 | |
| Qol Medical, LLC | $26.33 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $14.87 | 2021 | |
| Daiichi Sankyo INC. | $14.31 | 2019 | |
| Gilead Sciences, INC. | $14.29 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.11 | 2021 | |
| Braintree Laboratories, INC. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Dichiara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.